INVO Fertility
Manufacturing · Florida, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
5582 Broadcast Ct, Sarasota, Florida, 34...Phone Number
(978) 878-9505Website
www.invofertility.comRevenue
$6.9 MillionStock Symbol
IVFIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
1
1
1
About INVO Fertility
INVO Bioscience, Inc., a medical device company, provides novel solutions in assisted reproductive technologies to the reproductive health care community in the United States, Canada, South and Central America, Latin America, India, the Middle East, and Africa. The company offers the INVOcell device that is used in infertility treatment for the incubation of eggs and sperm during fertilization, and early embryo development. It also offers INVO procedure, an alternative infertility treatment that enables the conception and embryo development inside the womans body. The company sells its products through established and new distributors, IVF centers, and physicians, as well as directly to the physicians. INVO Bioscience, Inc. is based in Medford,...Explore more
INVO Fertility Org Chart
Get the full picture
Sign in to uncover key details.
Get the full picture
Sign in to uncover key details.
Show More
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is INVO Fertility your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if INVO Fertility is spiking on competitors!
Product Launch: Get notified when INVO Fertility launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at INVO Fertility
Click to see if INVO Fertility had a recent Job posting/layoffs
Funding: Get notified immidiatlly once INVO Fertility has new funding data
INVO Fertility, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on INVO Fertility recently announced quarterly report
Check if INVO Fertility has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Find VP level buyers at INVO Fertility
Find more new buyers
Company Profile Activity
Activity Insights
INVO Fertility is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
INVO Fertility is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about INVO Fertility.
INVO Fertility financials insights
Gather financial insights about INVO Fertility, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Debt
$150K
Other Financing Round
$3M
INVO Fertility Tech Stack
A closer look at the technologies used by INVO Fertility
Most Recent Scoops
Promotion
Executive Move
Executive Moves, Promotion
Promotion
Executive Move
Executive Moves, Promotion
Mergers & Acquisitions (M&A)
Mergers & Acquisitions, Acquisitions, Mergers
Mergers & Acquisitions (M&A)
Mergers & Acquisitions, Acquisitions, Mergers
Lateral Move
Executive Move
Executive Moves, Lateral Move
INVO Fertility News & Media
INVO Fertility Announces Fiscal Year 2025 Financial Results
SARASOTA, Fla., June 02, 2026 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (Nasdaq: IVF) (“INVO Fertility” or the “Company”), a healthcare fertility company focused on the establishment, acquisition, and operation of fertility clinics and related businesses and technologies, today announced fiscal year 2025 financial results.INVO Fertility Receives Nasdaq Notification Regarding Late Filing of Annual Report on Form 10-K
SARASOTA, Fla., April 29, 2026 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (Nasdaq: IVF) (“INVO” or the “Company”), a healthcare services fertility company focused on expanding access to advanced reproductive treatment through the establishment, acquisition and operation of fertility clinics and related businesses and technologies, today announced that on April 23, 2026, it received a written notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”)INVO Fertility Announces a 1:5 Reverse Stock Split Effective Pre-Market Opening on March 27, 2026
SARASOTA, Fla., March 25, 2026 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (“INVO”) (NASDAQ: IVF), a healthcare company focused on the fertility market, announced today that it will effect a 1-for-5 reverse split of its issued and outstanding and of its authorized common stock effective as of 12:01 a.m. Eastern Time on March 27, 2026. Commencing with the opening of trading on The Nasdaq Capital Market on March 27, 2026, the Company’s common stock will tradeINVO Fertility Announces Availability of Advanced Incubation Technology at its Wisconsin Clinic
Time-Lapse Incubation Provides Additional Cutting-Edge Solution for Patient Care Time-Lapse Incubation Provides Additional Cutting-Edge Solution for Patient Care
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding INVO Fertility
Sign Up For FreeTo access detailed company insights
INVO Bioscience, Inc., a medical device company, provides novel solutions in assisted reproductive technologies to the reproductive health care community in the United States, Canada, South and Central America, Latin America, India, the Middle East, and Africa. The company offers the INVOcell device that is used in infertility treatment for the inc... Read More
